Literature DB >> 12365202

Chronopharmacokinetics of acetaminophen in healthy human volunteers.

J A Kolawole1, P D Chuhwak, S O Okeniyi.   

Abstract

Acetaminophen is a common antipyretic-analgesic drug usually administered orally any time of the day. It was however claimed by Belanger et al, (1985) to have a longer elimination half-life (t1/2 beta) in rats when administered by 2100 h, than at 0700 h. This work is designed to investigate this claim in man and to study the circadian changes in acetaminophen pharmacokinetics at three dosing times; 0730 h, 1300 h and 2100 h. Seven healthy male volunteers, age 26.28 +/- 3.01 years, weighing 65.00 +/- 2.2 kg, were administered with 1000 mg oral acetaminophen at the three circadian time after a period of fast of not less than 4 h. The pharmacokinetic values obtained, though varied, are found to be in similar ranges with previously reported values. The absorption parameters ka and mean Tmax were significantly altered with dosing at 0730 h and 2100 h while the mean t1/2 alpha and ka were also significantly changed. There was a significant difference (P < 0.05) between the Tmax values obtained at 2100 h and that of 0730 h, while the 34.9% increase at dosing time 1300 h over 0730 h dosing times is not statistically significant (P > 0.05). Cmax was found to be 22.31 +/- 4.24 mcg/ml for 0730 h dosing time, while a decrease of 9.64 and 11.7% over this value was recorded for dosing time 1300 h and 2100 h respectively. The changes are however not statistically significant (P > 0.05). AUCo-a at 0730 h did not show any significant change when compared with values obtained at 1300 h and 2100 h, but there was a significant difference between the values obtained at 1300 h and 2100 h. Elimination half-life, t1/2 beta was found to be 1.68 +/- 0.67 h at 0730 h. There was an increase of 13.1% and 20.83% over this value at 1300 h and 2100 h. These increases were not statistically significant (p > 0.05). Although there are similar increases in t1/2 beta at the 1300 h and 2100 h dosing time as reported by Belanger et al 1985, the increases were not statistically significant in man.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365202     DOI: 10.1007/BF03190458

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

Review 1.  Chronopharmacokinetics. Current status.

Authors:  B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

2.  Diurnal variations in the transferases and hydrolases involved in glucuronide and sulfate conjugation of rat liver.

Authors:  P M Bélanger; M Lalande; G Labrecque; F M Dore
Journal:  Drug Metab Dispos       Date:  1985 May-Jun       Impact factor: 3.922

3.  Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction.

Authors:  C A Naranjo; E M Sellers; H G Giles; J G Abel
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

4.  Letter: paracetamol measurement.

Authors:  J P Glynn; S E Kendal
Journal:  Lancet       Date:  1975-05-17       Impact factor: 79.321

5.  Effects of posture and sleep on the pharmacokinetics of paracetamol (acetaminophen) and its metabolites.

Authors:  R H Rumble; M S Roberts; M J Denton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

6.  Chronopharmacology: a therapeutic frontier.

Authors:  F Halberg; H F Kabat; P Klein
Journal:  Am J Hosp Pharm       Date:  1980-01
  6 in total
  4 in total

1.  Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.

Authors:  Agnieszka Karbownik; Agnieszka Bienert; Włodzimierz Płotek; Tomasz Grabowski; Magdalena Cerbin-Koczorowska; Anna Wolc; Edmund Grześkowiak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

2.  Quantification of Low-Level Drug Effects Using Real-Time, in vitro Measurement of Oxygen Consumption Rate.

Authors:  Adam Neal; Austin M Rountree; Craig W Philips; Terrance J Kavanagh; Dominic P Williams; Peter Newham; Gamal Khalil; Daniel L Cook; Ian R Sweet
Journal:  Toxicol Sci       Date:  2015-09-22       Impact factor: 4.849

Review 3.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

4.  Safety and population pharmacokinetic analysis of intravenous acetaminophen in neonates, infants, children, and adolescents with pain or Fever.

Authors:  Athena F Zuppa; Gregory B Hammer; Jeffrey S Barrett; Brian F Kenney; Nastya Kassir; Samer Mouksassi; Mike A Royal
Journal:  J Pediatr Pharmacol Ther       Date:  2011-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.